| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.488 | 4.838 | 2.841 | 2.604 | 1.087 | 365 | 7.604 | 9.368 | 12.672 | 9.855 |
| Total Income - EUR | 4.488 | 4.838 | 2.841 | 2.604 | 1.087 | 365 | 7.604 | 9.368 | 12.672 | 9.855 |
| Total Expenses - EUR | 7.305 | 10.356 | 7.714 | 5.148 | 2.932 | 7.046 | 12.322 | 6.692 | 11.997 | 17.557 |
| Gross Profit/Loss - EUR | -2.817 | -5.518 | -4.873 | -2.544 | -1.844 | -6.681 | -4.718 | 2.676 | 676 | -7.702 |
| Net Profit/Loss - EUR | -2.951 | -5.615 | -4.924 | -2.619 | -1.877 | -6.692 | -4.946 | 2.395 | 567 | -7.702 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Medy & John S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.139 | 3.009 | 1.999 | 778 | 1.366 | 1.755 | 485 | 487 | 824 | 2.438 |
| Inventories | 2.845 | 2.809 | 1.942 | 700 | 1.282 | 1.258 | 0 | 0 | 0 | 0 |
| Receivables | 110 | 88 | 0 | 28 | 0 | 496 | 485 | 487 | 485 | 482 |
| Cash | 184 | 112 | 58 | 50 | 84 | 1 | 0 | 0 | 339 | 1.955 |
| Shareholders Funds | -2.919 | -8.504 | -13.283 | -15.658 | -17.232 | -26.374 | -30.735 | -28.435 | -27.781 | -35.329 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.057 | 11.513 | 15.282 | 16.436 | 18.598 | 28.129 | 31.220 | 28.922 | 28.605 | 37.767 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1520 - 1520" | |||||||||
| CAEN Financial Year |
1520
|
|||||||||
Comments - Medy & John S.r.l.